Hospitals Episurf Medical has received initial feedback from the US FDA on the IDE application for the Episealer® knee implant byJosh SandbergJuly 31, 2018
Hospitals Episurf Medical submits IDE application to the US FDA for the Episealer® knee implant byJosh SandbergJune 28, 2018
Extremities Episurf Medical enters into distribution agreement in Hong Kong and establishes subsidiary in the US byJosh SandbergApril 27, 2018
Hospitals Episurf Medical’s knee products approved for marketing and sale in Spain byJosh SandbergApril 4, 2018
Extremities Episurf Medical in the final stages of development of an ankle implant byJosh SandbergFebruary 15, 2018
Hospitals Top Stories Episurf Medical continues its communication with the US FDA for market acceptance in the U.S. byJosh SandbergMay 16, 2017
Financial Episurf Medical – Interim Report, 1 January – 30 September, 2015 byJosh SandbergNovember 9, 2015
